Journals / Türk Oftalmoloji Dergisi / 2003 / Cilt: 33 - Sayı: 2/1

Risk factors for vitreous hemorrhage in subjects with diabetic retinopathy

Diyabetik retinopatili hastalarda vitreus hemorajisi üzerine etkili risk faktörleri

Pages
310–314
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: In patients with diabetic retinopathy, it is important to determine the risk fac-tors for vitreous hemorrhage in identifying the patients under risk, and also for their follow-up and treatment.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: To determine the risk factors for vitreous hemorrhage in subjects with diabetic retinopathy. .
📊
Key Findings & Data:Methods: 177 eyes of 138 patients with vitreous hemorrhage (Study group) and 1397 eyes of 650 patients without vitreous hemorrhage (Control group), attending to our clinic due to diabetic retinopathy were retrospectively analyzed.
💡
Conclusion & Impact:Conclusion: In patients with diabetic retinopathy, it is important to determine the risk fac-tors for vitreous hemorrhage in identifying the patients under risk, and also for their follow-up and treatment.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Purpose: To determine the risk factors for vitreous hemorrhage in subjects with diabetic retinopathy. . Methods: 177 eyes of 138 patients with vitreous hemorrhage (Study group) and 1397 eyes of 650 patients without vitreous hemorrhage (Control group), attending to our clinic due to diabetic retinopathy were retrospectively analyzed. Age, gender, age at the onset of diabetes, duration of diabetes, type of diabetes treatment, hemoglobin Ale (HbAlc) level, type of diabetes and presence of hypertension (HT) were the factors, which were evaluated for their effects on vitreous hemorrhage. The multivariate-adjusted association between these factors and vitreous hemorrhage was evaluated with logistic regression analysis. On the other hand, Chisquare and Student-t tests were used to investigate the independent effects of these factors on vitreous hemorrhage. Results: As analyzed by multiple logistic regression model, HbAlc level was found to be the statistically significant risk factor for vitreous hemorrhage (p0,05). On the other hand, when the factors were investigated independently, patients with diabetic retinopathy between 18 and 39 years old, under 30 years of age at the onset of diabetes, type 1 diabetes, insulin treatment and high HbAlc level were the statistically significant factors for vitreous hemorrhage (p0,05). Conclusion: In patients with diabetic retinopathy, it is important to determine the risk fac-tors for vitreous hemorrhage in identifying the patients under risk, and also for their follow-up and treatment.

Özet

Amaç: Diyabetik retinopatili hastalarda, vitreus hemorajisi üzerinde etkili olan risk faktörlerini belirlemek. Yöntem: Diyabetik retinopati nedeni ile kliniğimize başvuran vitreus hemorajili 138 hastanın 177 gözü (Çalışma grubu) ve vitreus hemorajisi olmayan diyabetik retinopatili 650 hastanın 1397 gözü (Kontrol grubu) retrospektif olarak incelendi. Vitreus hemorajisine etkileri araştırılan faktörler; yaş, cins, diyabetin başlangıç yaşı, diyabet süresi, diyabetin tedavi şekli, glikolize hemoglobin (HbAlc) seviyesi, diyabetin tipi ve hipertansiyon (HT) varlığı idi. Vitreus hemorajisi ve bu faktörler arasındaki çok değişkenli ilişki, lojistik regresyon analizi ile değerlendirildi. Öte yandan, faktörlerin birbirinden bağımsız olarak vitreus hemorajisi üzerine etkilerinin incelenmesinde, Ki-kare ve Student t-testleri kullanıldı. Bulgular: Lojistik regresyon analizinde, vitreus hemorajisine istatistiksel olarak anlamlı düzeyde yol açan faktörün HbAlc seviyesi olduğu bulunurken (p0,05). Faktörler birbirinden bağımsız olarak incelendiğinde ise, 18-39 yaş arasındaki diyabetik retinopatili hastalar, diyabetin 30 yaşın altında başlaması, tip l diyabet, diyabetin tedavisi için insulin kullanımı ve yüksek HbAlc seviyesinin istatistiksel olarak anlamlı düzeyde vitreus hemorajisi için risk faktörleri olduğu bulunurken (p0,05). Sonuç: Diyabetik retinopatisi olan hastalarda vitreus hemorajisi üzerine etkili olan risk faktörlerinin belirlenmesi; riskli hasta grubunun tanınması, takibi ve tedavisi açısından önemlidir.

🔖

Cite This Article

ÖZMEN, D., KARAAĞAÇ, H., BAYRAK, Y., YANYALI, İ. A., NOHUTÇU, A. F. (2022). Risk factors for vitreous hemorrhage in subjects with diabetic retinopathy. Türk Oftalmoloji Dergisi, Cilt: 33 - Sayı: 2/1, 310–314. https://ajindex.com/articles/638999

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Winslow RL, Taylor BC: Spontaneous vitreous hemorrhage: etiology and management. South Med J 1980; 73: 1450-2 2. Butner RW, McPherson: Spontaneous vitreous hemorrha- ge. Ann Ophthalmol 1982; 14: 268-70 3. Lindgren G, Sjodell L, Lindblom B: A prospective study of dense spontaneous vitreous hemorrhage. Am J Oph- thalmol 1995; 119: 458-65 4. Pichard E, Serre L, Coulibaly D: General causes of retinal and vitreous hemorrhages in Mali. Bull Soc Pathol Exot 1991; 84:: 1021-7 5. Dana MR, Werner MS, Viana MAG, Shapiro MJ: Spon- taneous and traumatic vitreous hemorrhage. Ophthalmo- logy 1993; 100: 1377-83 6. Spraul CW, Grossniklaus HE: Vitreous hemorrhage. Surv Ophthalmol 1997; 42: 36-39 7. Morse PH, Aminlari A, Scheie HG: Spontaneous vitreous hemorrhage. Arch Ophthalmol 1974; 92: 297-8 8. Diabetic Control and Complications Trial Research Gro- up. The effect of intensive diabetes treatment on the prog- ression of diabetic retinopathy in insulin dependent diabe- tes mellitus. Arch Ophthalmol 1995; 113: 36-51 9. Fong DS, Ferris FL, Davis MD, Chew EY: The Early Treatment Diabetic Retinopathy Study Research Group: Causes of severe visual loss in the early treatment diabe- tic retinopathy study: ETDRS Report No.24. Am J Oph- thalmol 1999; 127: 137-141 10. Neely, Quillen, Schachat, Gardner, Blankenship: Preven- tion and treatment of diabetes and its complications. The Medical Clinics of North America 1998; 82: 847-874 11. Schulman JA: Diabetes Mellitus. In: Intravitreal surgery: Principles and practice, Peyman GA ed. Norwalk, CT, Appleton and Lange. 1994; 419-487 12. Diabetic Control and Complications Trial Research Gro- up: Progression of retinopathy with intensive versus con- ventional treatment in the Diabetes control and complica- tions trial. Ophthalmology 1995; 102: 647-661 13. Diabetic Retinopathy Vitrectomy Study Research Group: Early vitrectomy for severe vitreous hemorrhage in diabe- tic retinopathy. Two year results of randomized trial. Dia- betic Retinopathy Vitrectomy Study Report 2. Arch Oph- thalmol 1985; 103: 1644-1652